Chinese Traditional and Herbal Drugs
|
2025, 56(11): 3947-3958
Mechanism of Dracocephalum moldavica in improving chronic kidney disease in rats based on network pharmacology and experimental verification
Full
HENG Yuanyuan1,2, TAN Meie2, ZHUMABIEKE Shuhela2, WU Tong3, LAN Wei1,2, YU Ning2
Affiliations
1 College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830017, China;
2 Key Laboratory of Xinjiang Uygur Antonomus Medicine, Xinjiang Uygur Antonomus Institute of Materia Medica, Urumqi 830000, China;
3 National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China
doi: 10.7501/j.issn.0253-2670.2025.11.015
Outline
Objective To explore the effect and mechanism of Dracocephalum moldavica on chronic kidney disease (CKD) through network pharmacology combined with animal experiments. Methods The active ingredients of D. moldavica were obtained through literature review, the intersection targets of active ingredients and CKD were obtained using network pharmacology. The “active ingredient-target-disease” network and potential target interaction network were constructed, the core targets and core components were screened by degree values. Gene ontology (GO) function and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis of core targets were performed using Matescape online platform. CKD rat model was established, Compound α-Ketoacid Tablets or D. moldavica extracts were given for intervention for 28 d. After the end of administration, blood was taken to measure urea nitrogen and creatinine levels; Hematoxylin-eosin (HE) staining was used to observe the pathological changes in renal tissue of rats in each group; Western blotting was used to detect the expressions of α-smooth muscle actin (α-SMA), carbonic anhydrase IV (CAIV), β-catenin, matrix metalloproteinase 9 (MMP9) and fibronectin (FN) in renal tissues of rats in each group. Results A total of 61 active ingredients, 789 related targets, 2 194 CKD targets, and 349 intersecting targets between D. moldavica and CKD were obtained. The enrichment analysis results showed that D. moldavica might regulate CAIV, MMP9, aldose reductase (AKR1B1) and other core targets through 7,4′-dihydroflavone, luteolin, scrophulein, luteolin-7-O-glucoside, luteolin-7-glucuronide and other core components, and act on cancer, lipid and atherosclerosis, phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) signal pathway and other pathways to prevent CKD. Animal experiment results showed that compared with model group, D. moldavica extract could significantly reduce the levels of urea nitrogen and creatinine in serum of rats (P < 0.05, 0.01), improve nephron damage, significantly down-regulate the protein expressions of CAIV, α-SMA, MMP9 and FN in renal tissue (P < 0.05, 0.01), and up-regulate the protein expression of β-catenin (P < 0.05). Conclusion D. moldavica exerts therapeutic effects on CKD through multiple components and targets, and its main active ingredients may improve CKD by regulating the expressions of β-catenin, α-SMA, MMP9, and FN through CAIV.
Dracocephalum moldavica L.
/
chronic kidney disease
/
renal fibrosis
/
CAIV
/
luteolin-7-O-β-D-glucuronide
/
rosmarinic acid
/
leptomerine
/
7,4'-dihydroflavone
/
luteolin
/
scrophulein
/
luteolin-7-O-glucoside
衡元元, 谭梅娥, 舒合拉·朱马别克, 吴彤, 兰卫, 于宁.
基于网络药理学和实验验证探讨香青兰改善慢性肾脏疾病的作用机制.
中草药,
2025
, 56
(11)
: 3947
-3958
.
DOI: 10.7501/j.issn.0253-2670.2025.11.015
HENG Yuanyuan, TAN Meie, ZHUMABIEKE Shuhela, WU Tong, LAN Wei, YU Ning.
Mechanism of Dracocephalum moldavica in improving chronic kidney disease in rats based on network pharmacology and experimental verification[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(11)
: 3947
-3958
.
DOI: 10.7501/j.issn.0253-2670.2025.11.015
Year 2025 volume 56 Issue 11
47
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.11.015
- Receive Date:2024-09-03
- Online Date:2026-11-13